4597.T
Solasia Pharma K.K.
グロース · 医薬品 · 医薬品 · JP
JPY 29.00
+0.00%Year over year
Reported trailing growth
- Revenue
- +35.8%
- EBITDA
- —
- EBIT
- +55.9%
- EPS
- +61.5%
- Free cash flow
- —
- Operating cash flow
- +18.0%
Forward estimates
Based on analyst estimates
- Revenue
- +203.0%
- EBITDA
- —
- EPS
- +36.2%
Three-year CAGR
- Revenue
- -26.8%
- EBITDA
- —
- EBIT
- +55.9%
- Net income
- +54.9%
- EPS
- +62.2%
- Free cash flow
- +18.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026